RETRACTED: Nanoscale Donor–Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity
Journal of the American Chemical Society · 23.07.2025 · 147 (29) · 25622-25634
DOI: 10.1021/jacs.5c06488 ↗Kurz gefasst
Zurückgezogene Publikation in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.07.2025. Verfasst von Jing Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States. Hauptthemen laut MEDLINE: Mitochondria, Metal-Organic Frameworks, Antineoplastic Agents, Ultrasonic Therapy. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Institutes of Health.
Abstract (Originalsprache)
Sonodynamic therapy (SDT) based on O2-dependent type II sonosensitizers (SSs) is limited by the hypoxic tumor microenvironment and aggregation-induced quenching (AIQ) of SSs. Type I SSs can generate reactive oxygen species (ROS) with reduced O2 dependence, but their efficacy is still constrained by the high electron-hole recombination rates and low ROS yields. Here, we report the synthesis of a novel two-dimensional nanoscale covalent organic framework (nCOF), Td-Pc, for mitochondria-targeted type I/II SDT. Td-Pc is constructed from staggered zinc-phthalocyanine tetra-anhydride (Pc) units and 4,4'-(thiazolo[5,4-d]thiazole-2,5-diyl)dianiline linkers, forming a donor-acceptor nCOF structure. This structural arrangement significantly alleviates the AIQ of Pc, enhances acoustic electron dissociation and transport, and promotes tumor accumulation. Consequently, Td-Pc enables efficient ROS generation throughout tumor tissues via both type I and II SDT mechanisms. The resulting mitochondrial oxidative stress induces immunogenic cancer cell pyroptosis and upregulates PD-L1 expression. When combined with an anti-PD-L1 monoclonal antibody, Td-Pc-mediated SDT elicits a robust antitumor immune response, leading to effective regression of orthotopic pancreatic ductal adenocarcinoma and bilateral triple-negative breast cancer without causing side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, The University of Chicago, Chicago, Illinois 60637, United States.
- Department of Radiation and Cellular Oncology and Ludwig Center for Metastasis Research, The University of Chicago, Chicago, Illinois 60637, United States.
ORCID-Profile: Jing Liu, Zhihao Zhao, Chenghua Deng, Richard Zanni, Wenbin Lin
Förderung
- National Institutes of Health
Zitieren
APA
Liu, J., Zhao, Z., Deng, C., Zanni, R., Weichselbaum, R. R., & Lin, W. (2025). RETRACTED: Nanoscale Donor–Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity. Journal of the American Chemical Society, 147(29), 25622-25634. https://doi.org/10.1021/jacs.5c06488
Vancouver
Liu J, Zhao Z, Deng C, Zanni R, Weichselbaum RR, Lin W. RETRACTED: Nanoscale Donor–Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity. Journal of the American Chemical Society. 2025;147(29):25622-25634. doi:10.1021/jacs.5c06488
BibTeX
@article{Liu2025,
author = {Liu, Jing and Zhao, Zhihao and Deng, Chenghua and Zanni, Richard and Weichselbaum, Ralph R and Lin, Wenbin},
title = {RETRACTED: Nanoscale Donor–Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity},
journal = {Journal of the American Chemical Society},
year = {2025},
volume = {147},
number = {29},
pages = {25622--25634},
doi = {10.1021/jacs.5c06488}
}
EUVIMED